Back
Company
Lunit
vendor1 tracked tool
Company Intelligence
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW
10 hours agodeployment
Lunit INSIGHT DBT v1.1 FDA 510(k) Clearance
a day agofda
New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images
3 days agoevidence
Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region
5 days agodeployment
Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening
5 days agoevidence
Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice
5 days agofda
A large validation study of AI-powered PD-L1 analyzer compared to pathologists’ assessment of PD-L1 expression in lung cancer
6 days agoevidence
Lunit’s AI Now Powers Cancer Screening for Over 8.5 Million People Across Italy’s Public Health System
6 days agodeployment
Lunit Partners with Severance Hospital to Expand Medical AI Foundation Model
7 days agodeployment
Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program
10 days agodeployment
Health system will use AI instead of radiologists for breast imaging 2nd reads
11 days agodeployment
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
12 days agodeployment
Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region
12 days agodeployment
Lunit to deploy AI chest X-ray solution to Saudi Arabia's largest medical group
18 days agodeployment
Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
20 days agodeployment